Donna R. Cryer, JD is Founder, President and Chief Executive Officer of the Global Liver Institute (GLI), the only patient-driven liver health nonprofit operating in the US and Europe. She has channeled her personal experience as a patient with inflammatory bowel disease and a 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. GLI established and leads the 70-member NASH Council, created the Beyond the Biopsy Campaign to advance non-invasive technologies in the liver field, and represents the patient community in the FNIH NIMBLE Consortium and the Liver Forum. Mrs. Cryer serves on the Boards of Directors of The Innovation and Value Initiative (IVI), the Sibley Memorial Hospital/Johns Hopkins Medicine, the Executive Committee for the Clinical Trials Transformation Initiative and the Executive Advisory Committee for Tivity Health (NASDAQ: TVTY). Mrs. Cryer received an undergraduate degree from Harvard/Radcliffe Colleges and a Juris Doctorate from the Georgetown University Law Center.